It is known that TLR7, TLR9, and IFN-α pathways play vital roles in the pathogenesis of SLE, we therefore evaluated the effects of these pathways on CD180 expression in human PBMCs. The gene discussed is TLR9; the disease is systemic lupus erythematosus.